EnteroBiotix, a Glasgow-based biotech firm specializing in microbiome therapeutics, has successfully closed a funding round totaling £27M (approximately €31.46M). This round combines £15.7M (approximately €18.29M) in fresh equity with the conversion of £11.6M (approximately €13.51M) of loan notes into equity.